Therefore, understanding the function of the APE1 gene during the therapeutic response to PDT treatment in lung cancer and selecting more effective ways to inhibit APE1 expression will be expected to improve effectively the sensitivity of lung cancer cells to PDT treatment. This evidence concerns the gene APEX1 and lung carcinoma.